Literature DB >> 15671521

From microarray to bedside: targeting NF-kappaB for therapy of lymphomas.

Arnold B Rabson1, David Weissmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15671521

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.

Authors:  Leon Bernal-Mizrachi; Christine M Lovly; Lee Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

2.  Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma.

Authors:  Shiri Diskin; Janardan Kumar; Zhiyi Cao; Joel S Schuman; Tim Gilmartin; Steven R Head; Noorjahan Panjwani
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

3.  Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro.

Authors:  Dariush Mokhtari; Tingting Li; Tao Lu; Nils Welsh
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

4.  An gene expression pattern.

Authors:  Manjul Tiwari
Journal:  J Nat Sci Biol Med       Date:  2012-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.